Abstract: In order to establish a TaqMan MGB fluorescent-quantitative PCR (FQ-PCR) assay for detecting canine parvovirus (CPV) specifically, sensitively and rapidly, a highly sensitive and specific TaqMan MGB FQ-PCR assay was developed using the specific primers and TaqMan MGB probe designed basing on the conservative sequences of VP2 gene of CPV in GenBank. The sensitivity, specificity and repetition assay of FQ-PCR assay were tested, and 46 clinic suspicious CPV infected samples were detected by the FQ-PCR assay in contrast to the routine PCR method. The results indicated that the FQ-PCR was successfully established. The developed FQ-PCR assay was able to detect as little as 1×10¹copies/μL of recombinant pGEX-T/CPV plasmid DNA, and the sensitivity of which was 100 times more than that of the routine PCR. The specificity assay exhibited that positive signals could be obtained from recombinant pGEM-T/CPV plasmid, but not from the genomic DNA or total cDNA of the other 5 kinds of pathogenic microorganism acting as the controls. The repetition tests were carried out by detection repeated 3 times for 3 different concentrations of recombinant pGEX-T/CPV plasmid, and the results indicated that the FQ-PCR was reproducible. Twenty-three positive results from 46 clinic suspicious CPV infected samples were obtained, which showed the better sensitivity than that of the routine PCR, with 19 positive samples from the same 46 suspected samples. The study suggested that the CPV FQ-PCR method was successfully established, and suitable for clinic rapid diagnosing of CPV and early detection of latent infection.

Key words:

canine parvovirus；TaqMan MGB probe；FQmso-bidi-font-family: 宋体" lang="EN-US">-PCR；establishment；application